Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach

被引:62
作者
Perdih, Andrej [1 ]
Kovac, Andreja [2 ]
Wolber, Gerhard [3 ,4 ,5 ]
Blanot, Didier [6 ]
Gobec, Stanislav [2 ]
Solmajer, Tom [1 ]
机构
[1] Natl Inst Chem, Ljubljana 1001, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia
[3] Inte Ligand GmbH, A-1070 Vienna, Austria
[4] Univ Innsbruck, Inst Pharm, A-6020 Innsbruck, Austria
[5] Univ Innsbruck, CMBI, A-6020 Innsbruck, Austria
[6] Univ Paris Sud, IBBMC, CNRS, UMR 8619, F-91405 Orsay, France
关键词
MurD and MurE enzymes; Virtual screening; Three-dimensional structure-based pharmacophores; Molecular docking; Antibacterial agents; Drug design; BIOSYNTHESIS ENZYMES MURD; CELL-WALL BIOSYNTHESIS; ALANYL-D-GLUTAMATE; PEPTIDOGLYCAN BIOSYNTHESIS; PHOSPHINATE INHIBITORS; L-ALANINE; DERIVATIVES; DYNAMICS; BINDING; DESIGN;
D O I
10.1016/j.bmcl.2009.03.141
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The peptidoglycan biosynthetic pathway provides an array of potential targets for antibacterial drug design, attractive especially with respect to selective toxicity. Within this pathway, the members of the Mur ligase family are considered as promising emerging targets for novel antibacterial drug design. Based on the available MurD crystal structures co-crystallised with N-sulfonyl glutamic acid inhibitors, a virtual screening campaign was performed, combining three-dimensional structure-based pharmacophores and molecular docking calculations. A novel class of glutamic acid surrogates-benzene 1,3-dicarboxylic acid derivatives-were identified and compounds 14 and 16 found to possess dual MurD and MurE inhibitory activity. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2668 / 2673
页数:6
相关论文
共 37 条
[1]  
*ACC SOFTW, CAT
[2]   Large-scale preparation, purification, and crystallization of UDP-N-acetyluramoyl-L-alanine:: D-glutamate ligase from Escherichia coli [J].
Auger, G ;
Martin, L ;
Bertrand, J ;
Ferrari, P ;
Fanchon, E ;
Vaganay, S ;
Pétillot, Y ;
van Heijenoort, J ;
Blanot, D ;
Dideberg, O .
PROTEIN EXPRESSION AND PURIFICATION, 1998, 13 (01) :23-29
[3]   Cytoplasmic steps of peptidoglycan biosynthesis [J].
Barreteau, Helene ;
Kovac, Andreja ;
Boniface, Audrey ;
Sova, Matej ;
Gobec, Stanislav ;
Blanot, Didier .
FEMS MICROBIOLOGY REVIEWS, 2008, 32 (02) :168-207
[4]   A MurF inhibitor that disrupts cell wall biosynthesis in Escherichia coli [J].
Baum, Ellen Z. ;
Crespo-Carbone, Steven M. ;
Klinger, Alexandra ;
Foleno, Barbara D. ;
Turchi, Ignatius ;
Macielag, Mark ;
Bush, Karen .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) :4420-4426
[5]   Determination of the MurD mechanism through crystallographic analysis of enzyme complexes [J].
Bertrand, JA ;
Auger, G ;
Martin, L ;
Fanchon, E ;
Blanot, D ;
La Beller, D ;
van Heijenoort, J ;
Dideberg, O .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (03) :579-590
[6]  
Bouhss A, 2002, METHOD ENZYMOL, V354, P189
[7]   The biosynthesis of peptidoglycan lipid-linked intermediates [J].
Bouhss, Ahmed ;
Trunkfield, Amy E. ;
Bugg, Timothy D. H. ;
Mengin-Lecreulx, Dominique .
FEMS MICROBIOLOGY REVIEWS, 2008, 32 (02) :208-233
[8]   Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement [J].
Chopra, Ian ;
Schofield, Christopher ;
Everett, Martin ;
O'Neill, Alex ;
Miller, Keith ;
Wilcox, Mark ;
Frere, Jean-Marie ;
Dawson, Mike ;
Czapiewski, Lloyd ;
Urleb, Uros ;
Courvalin, Patrice .
LANCET INFECTIOUS DISEASES, 2008, 8 (02) :133-139
[9]   Biochemical characterization of an inhibitor of Escherichia coli UDP-N-acetylmuramyl-L-alanine ligase [J].
Ehmann, DE ;
Demeritt, JE ;
Hull, KG ;
Fisher, SL .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1698 (02) :167-174
[10]   Structure and function of the Mur enzymes: development of novel inhibitors [J].
El Zoeiby, A ;
Sanschagrin, F ;
Levesque, RC .
MOLECULAR MICROBIOLOGY, 2003, 47 (01) :1-12